BHVN - biohavenpharma.com Uzoq muddatli majburiyatlarning kapitalga nisbati
Biohaven Ltd. (BHVN) uchun narxlar tendentsiyasi molekulalarni kashf qilishni ichki nazoratda saqlagan holda, ishlab chiqarish va sinovlarni uchinchi tomon pudratchilarga topshiradigan kompaniya dinamikasini aks ettiradi. Joriy ko'rsatkich 23.30 darajasida turibdi. Biznesning o'sishi qat'iy likvidlik boshqaruvi bilan birga epileptik qarshi dori vositalari sinovlarining muvaffaqiyatiga bog'liq. Innovatsion oqsil parchalash usullari va ion modulyatsiyasi og'ir miya patologiyalarini davolash uchun noyob asos yaratadi.
%3A%20Uzoq%20muddatli%20qarzning%20o'z%20kapitaliga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_BHVN_-_Biohaven-Ltd._-_Long-Term-Debt-to-Equity-Ratio "BHVN: Biohaven Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 28.10.2026 | 👁️GURU.Markets👁️")
Biohaven Ltd. kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning kapitalga nisbati Biohaven Ltd.|BHVN - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati biohavenpharma.com|BHVN - Kompaniyaning jamlangan qarzlari|Sof aktivlarga qarzlar Biohaven Ltd.|BHVN - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz Biohaven
Fundamental baholash:Biohaven Ltd
Ushbu ko'rsatkich biznesning tashqi qarzga bog'liqlik darajasini aniqlash uchun muddati bir yildan ortiq bo'lgan majburiyatlarni umumiy kapital bilan solishtirish orqali moliyaviy barqarorlikni baholaydi. Uzoq muddatli qarzning kapitalga nisbatini tahlil qilish orqali investor Biohaven Ltd. (BHVN) kompaniyasining aksiyadorlari tomonidan qo'llab-quvvatlangan holda, to'lovga qobiliyatsizlikning kritik xavfisiz epilepsiga qarshi dori vositalari uchun qimmatbaho klinik sinovlarni moliyalashtirish imkoniyatini baholashi mumkin.
Biohaven Ltd. kimlar bilan raqobatlashadi
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Biogen Inc|Neurocrine Biosciences Inc - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Regencell Corp RGC|Uzoq muddatli qarzning o'z kapitaliga nisbati AXSM (Axsome Therapeutics)|acadia-pharm.com - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Xenon (XENE)|VKTX: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati SUPN|Catalyst Corp (CPRX) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Denali Therapeutics|Uzoq muddatli qarzning o'z kapitaliga nisbati harmonybiosciences.com|AMLX (Amylyx Pharmaceuticals, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati TRVI (Trevi Therapeutics Inc)|PRAX: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Anavex Life Sciences Corp AVXL|Uzoq muddatli qarzning kapitalga nisbati CeriBell, Inc. (CBLL)|PRTA - Uzoq muddatli qarzning kapitalga koeffitsiyenti|ALEC: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Annexon Biosciences|Uzoq muddatli qarzning o'z kapitaliga nisbati Omeros Corp|Uzoq muddatli qarzning o'z kapitaliga nisbati Neurogene Therapeutics|AC Immune - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati VYGR (voyagertherapeutics.com)|NMRA - Uzoq muddatli qarzning o'z kapitaliga nisbati|SCLX - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning o'z kapitaliga nisbati Tevogen Bio Holdings, Inc. (TVGN)|ACOG: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Cognition Therapeutics (CGTX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati inhibikase.com|Cassava Sciences (SAVA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati Assertio Therapeutics|Uzoq muddatli qarzning kapitalga nisbati Coya Therapeutics, Inc. COYA|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi vistagen.com VTGN|Uzoq muddatli qarzning o'z kapitaliga nisbati OVID|Uzoq muddatli qarzdorlikning kapitalga nisbati acumenpharm.com ABOS|CRVO - Uzoq muddatli qarzning kapitalga nisbati|ATHE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati clene.com CLNN|Uzoq muddatli qarzning kapitalga koeffitsiyenti PepGen|Uzoq muddatli qarzning o'z kapitaliga nisbati Jupiter Neurosciences Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati RLMD|Uzoq muddatli qarzning o'z kapitaliga nisbati Annovis Bio ANVS|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi GRCE (gracetx.com)|AIFF - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi ANEW Medical KLTO|NRSN (NeuroSense Therapeutics, Ltd.) - Uzoq muddatli qarzning kapitalga nisbati|revivapharma.com (RVPH) - Uzoq muddatli majburiyatlarning kapitalga nisbati|MTVA: Uzoq muddatli qarzning o'z kapitaliga nisbati|NRXS (NeurAxis Inc.) - Uzoq muddatli qarzning kapitalga nisbati|HSDT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti PASG|Neuphoria Therapeutics Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati minervaneurosciences.com (NERV)|Uzoq muddatli qarzning kapitalga nisbati Athira Pharma ATHA|Uzoq muddatli qarzning o'z kapitaliga nisbati Addex Therapeutics Ltd. ADXN|Uzoq muddatli qarzning kapitalga nisbati ALZN (Alzamend)|CYCN: Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati PTIX|Pasithea Therapeutics Corp. (KTTA) - Uzoq muddatli majburiyatlarning kapitalga nisbati|CRGT - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti Avenue Therapeutics Inc.|Uzoq muddatli qarzning kapitalga nisbati BCLI|Uzoq muddatli qarzning kapitalga nisbati Cara Therapeutics Inc CARA|Uzoq muddatli qarzning o'z kapitaliga nisbati Chromocell Therapeutics CHRO|Uzoq muddatli qarzning o'z kapitaliga nisbati Eliem Therapeutics, Inc. ELYM|ITCI (Intra-Cellular) - Uzoq muddatli qarzning kapitalga nisbati|LBPH: Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Marinus|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi NKGen Biotech Corp|NRBO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti SAGE|Uzoq muddatli qarzning o'z kapitaliga nisbati Synaptogenix (SNPX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Trevena Inc. TRVN|Uzoq muddatli qarzning o'z kapitaliga nisbati Vigil Neuroscience, Inc. (VIGL)|Uzoq muddatli kreditlarning kapitalga nisbati Anew Medical Inc. WENA|Cerevel Therapeutics (CERE) - Uzoq muddatli qarzning kapitalga nisbati